KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Treasury Shares (2020 - 2025)

Globus Medical's Treasury Shares history spans 7 years, with the latest figure at $4.3 million for Q4 2025.

  • For Q4 2025, Treasury Shares rose 6317.91% year-over-year to $4.3 million; the TTM value through Dec 2025 reached $4.3 million, up 6317.91%, while the annual FY2025 figure was $4.3 million, 933.65% up from the prior year.
  • Treasury Shares reached $4.3 million in Q4 2025 per GMED's latest filing, up from $307000.0 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $5.0 million in Q3 2022 to a low of $27000.0 in Q2 2025.
  • Average Treasury Shares over 5 years is $1.3 million, with a median of $370000.0 recorded in 2024.
  • Peak YoY movement for Treasury Shares: plummeted 98.85% in 2022, then skyrocketed 6317.91% in 2025.
  • A 5-year view of Treasury Shares shows it stood at $29000.0 in 2021, then surged by 106.9% to $60000.0 in 2022, then soared by 1266.67% to $820000.0 in 2023, then crashed by 91.83% to $67000.0 in 2024, then surged by 6317.91% to $4.3 million in 2025.
  • Per Business Quant, the three most recent readings for GMED's Treasury Shares are $4.3 million (Q4 2025), $307000.0 (Q3 2025), and $27000.0 (Q2 2025).